Lisa Sammaritano, MD: Final Thoughts, ACR Guidelines on Reproductive Health
The recently published American College of Rheumatology guidelines on reproductive health is a great resource for rheumatologists.
Daniel Albert, MD: Telemedicine for Rheumatic Care
How rheumatologists use telemedicine during COVID-19.
Alan Kaye, MD, PhD: Treating Pain During COVID-19
Leveraging telemedicine during COVID-19.
Jeffrey Curtis, MD, MS, MPH: The Responsibility of Cardiovascular Risk Management in Rheumatology
An expert discusses the role of the rheumatologist in managing cardiovascular risk factors as well as current gaps in the field.
Alan Kaye, MD, PhD: The Intersection of Pain and Rheumatology
An expert explains resources for pain related to rheumatic conditions.
Randall Cron, MD, PhD: Multisystem Inflammatory Syndrome in Children
MIS-C is a condition recently recognized in children with COVID-19.
Lisa Sammaritano, MD: Rheumatic Diseases, Pregnancy, and the Importance of Communication
Rheumatologists and OB-GYNs must communicate openly with each other and to patients with rheumatic diseases who are considering pregnancy.
Nancy Lane, MD: The State of Osteoarthritis and Osteoporosis
An expert discusses the state of screening, diagnosing, and treating osteoarthritis and osteoporosis.
PASDAS Sensitive at Detecting Changes in Psoriatic Disease Activity
Which composite measures detect the highest level of changes in psoriatic disease activity.
Switching Antirheumatic Therapies Has Low Risk of Clinical Worsening
In the MONARCH OLE study, more than 50% of patients with rheumatoid arthritis who had low or inadequate response to adalimumab and switched to sarilumab experienced an improvement in disease activity.
Ixekizumab Improves r-axSpA Symptoms Affecting Quality of Life
Patient assessments measured fatigue, disease activity, global spinal pain, and spinal pain at night.
Ashley Crew, MD: The Relationship Between Healthcare Specialists
How providers of multiple specialists can come together to help 1 patient.
Ashley Crew, MD: Barriers to Topical Steroid Use
An expert dermatologist explains.
Randall Cron, MD, PhD: Cytokine Storm Syndrome and COVID-19
COVID-19 is associated with its own cytokine storm syndrome.
DMARDs for Patients With Rheumatoid Arthritis-Associated ILD
A majority of patients with the condition are on azathioprine or mycophenolate mofetil and mycophenolic acid.
IPAF Shows Demographic and Imaging Similarities with CTD-ILD
These findings suggest the possibility of a common underlying disease process between the two pathologies.
Ashley Crew, MD: Clinical Manifestations in Rheum Care Requiring Derm Consult
When a rheum patient might need to consult with a dermatologist.
Ashley Crew, MD: The Intersection of Dermatology and Rheumatology
How the 2 specialties play a role in each other.
Filgotinib Effective, Safe for Psoriatic Arthritis
Filgotinib was well-tolerated and sustained efficacy in a 52-week extension study.
Lisa Sammaritano, MD: Rheumatic Diseases in Pregnant Patients
An expert discusses the risks that rheumatic diseases pose for pregnancies as well as the conversations rheumatologists need to have with their patients.
Sarilumab Linked to Lower Odds of Unacceptable Pain in Rheumatoid Arthritis Patients
A post-hoc analysis of 3 randomized controlled trials reports on the associations between the IL-6 inhibitor and unacceptable or refractory pain.
Seropositive Antibodies Linked with Prevalence of Rheumatoid Arthritis-Associated ILD.
Other measures, like home oxygen dependency, all-cause mortality, and hospitalization for respiratory failures rates, had no apparent association with RF and/or ACPA status
Alan Kaye, MD, PhD: Alternate Therapies for Rheumatologic Pain
Alternate therapies can be more effective than opioids.
Filgotinib Safe, Effective for Rheumatoid Arthritis
There were no new safety signals and efficacy was sustained through 156 weeks.
Alan Kaye, MD, PhD: Rheumatology and Pain Management
Facets of managing pain for rheumatology patients.
Ustekinumab Safe and Efficacious in Young and Elderly Patients with Psoriatic Arthritis
According to a poster presented at CCR East 2020, patients <60 and ≥60 years old achieved minimal disease activity and cDAPSA low disease or remission.
Bisphosphonate Mitigates Gap in Osteoporosis Detection, Management
Early initiation following fragility fractures helps manage osteoporosis.
Current HLH Treatment Protocols Potentially Inadequate
Treatment approaches for the management of secondary HLH is problematic due to the heterogeneity of approaches and rarity of the condition.
Jeffrey Curtis, MD, MS, MPH: The Effects of Connective Tissue Diseases on Cardiovascular Risk
Managing CTDs may have an overall benefit on cardiovascular health.
ICD 10 Algorithm Accurately Identifies Rheumatoid Arthritis Patients
This is the first time such an algorithm was validated in a large US claims database.
